Teva Pharmaceutical Industries Limited (TLV:TEVA)
6,259.00
+277.00 (4.63%)
Aug 21, 2025, 5:28 PM IDT
TLV:TEVA Revenue
Teva Pharmaceutical Industries had revenue of $4.18B USD in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to $16.63B, up 2.07% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.
Revenue (ttm)
$16.63B
Revenue Growth
+2.07%
P/S Ratio
1.27
Revenue / Employee
$465.95K
Employees
35,686
Market Cap
71.33B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.54B | 698.00M | 4.40% |
Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Danel (Adir Yeoshua) | 2.81B |
Kamada | 571.15M |
Bait Bakfar | 104.50M |
SofWave Medical | 234.12M |
BrainsWay | 155.27M |
Novolog (Pharm-Up 1966) | 2.09B |
Ilex Medical | 922.08M |
InterCure | 238.85M |
Teva Pharmaceutical Industries News
- 23 hours ago - Teva Pharmaceutical: Tariff Relief Clears The Way For Reinvention - Seeking Alpha
- 4 days ago - Teva Debuts Autumn Winter 2025 Collection Inspired By “For Playground Earth” - Business Wire
- 4 days ago - How Is The Market Feeling About Teva Pharmaceutical Indus? - Benzinga
- 10 days ago - Teva Pharmaceutical continues gains for seven straight sessions - Seeking Alpha
- 17 days ago - Teva wins FDA label expansion for migraine therapy Ajovy in children and adolescents - Seeking Alpha
- 17 days ago - US FDA approves Teva's Ajovy for migraine prevention in children - Reuters
- 22 days ago - Teva's Big Pharma Comeback: Why I Think The Market Is Still Missing The Upside - Seeking Alpha
- 23 days ago - Teva CEO: Our supply chain puts us in a strong position - CNBC